LIBRAINFU Stock Overview
Libra Infusions Limited manufactures and sells injectable intravenous fluids in Bangladesh.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Libra Infusions Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ৳737.00 |
52 Week High | ৳1,146.67 |
52 Week Low | ৳445.73 |
Beta | 0 |
1 Month Change | -7.96% |
3 Month Change | -18.03% |
1 Year Change | 65.35% |
3 Year Change | 92.97% |
5 Year Change | 15.67% |
Change since IPO | 3,391.05% |
Recent News & Updates
Recent updates
Shareholder Returns
LIBRAINFU | BD Pharmaceuticals | BD Market | |
---|---|---|---|
7D | -3.5% | -1.4% | -2.0% |
1Y | 65.3% | -12.6% | -15.4% |
Return vs Industry: LIBRAINFU exceeded the BD Pharmaceuticals industry which returned -12.5% over the past year.
Return vs Market: LIBRAINFU exceeded the BD Market which returned -14.9% over the past year.
Price Volatility
LIBRAINFU volatility | |
---|---|
LIBRAINFU Average Weekly Movement | 5.8% |
Pharmaceuticals Industry Average Movement | 5.8% |
Market Average Movement | 5.8% |
10% most volatile stocks in BD Market | 9.3% |
10% least volatile stocks in BD Market | 3.5% |
Stable Share Price: LIBRAINFU has not had significant price volatility in the past 3 months.
Volatility Over Time: LIBRAINFU's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1976 | n/a | Roushon Alam | libragroupbd.com/libra_infusions.php |
Libra Infusions Limited manufactures and sells injectable intravenous fluids in Bangladesh. Its products are used in medical situations, including diuresis, surgical intervention, intoxication, sodium deficit, infections, and weakness. The company was formerly known as Libra Pharmaceutical Limited and changed its name to Libra Infusions Limited in 1999.
Libra Infusions Limited Fundamentals Summary
LIBRAINFU fundamental statistics | |
---|---|
Market cap | ৳1.67b |
Earnings (TTM) | ৳1.58m |
Revenue (TTM) | ৳197.03m |
0.0x
P/E Ratio0.0x
P/S RatioIs LIBRAINFU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LIBRAINFU income statement (TTM) | |
---|---|
Revenue | ৳197.03m |
Cost of Revenue | ৳119.14m |
Gross Profit | ৳77.89m |
Other Expenses | ৳76.30m |
Earnings | ৳1.58m |
Last Reported Earnings
Jun 30, 2019
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did LIBRAINFU perform over the long term?
See historical performance and comparison